Showing results (31-40 of 75) with videos related to
Sort By:
Pageof 8
Clinical Immunology (Orlando, Fla.)|October 11, 2016
Identification of a gene expression signature in peripheral blood of multiple sclerosis patients treated with disease-modifying therapiesChiara Cordiglieri, Fulvio Baggi, Pia Bernasconi, et al.Plos One|November 4, 2014
Autophagy, inflammation and innate immunity in inflammatory myopathiesCristina Cappelletti, Barbara Galbardi, Dimos Kapetis, et al.Journal of Cell Science|February 13, 2019
VAPB depletion alters neuritogenesis and phosphoinositide balance in motoneuron-like cells: relevance to VAPB-linked amyotrophic lateral sclerosisPaola Genevini, Maria Nicol Colombo, Rossella Venditti, et al.Neurology|December 21, 2012
Complete stable remission and autoantibody specificity in myasthenia gravisFulvio Baggi, Francesca Andreetta, Lorenzo Maggi, et al.Experimental Neurology|May 31, 2011
Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a longitudinal MRI studyStefania Marcuzzo, Ileana Zucca, Alfonso Mastropietro, et al.Journal of Neuropathology and Experimental Neurology|June 4, 2008
The kinesin superfamily motor protein KIF4 is associated with immune cell activation in idiopathic inflammatory myopathiesPia Bernasconi, Cristina Cappelletti, Francesca Navone, et al.Matrix Biology : Journal of the International Society for Matrix Biology|July 8, 2018
Exosomes and exosomal miRNAs from muscle-derived fibroblasts promote skeletal muscle fibrosisSimona Zanotti, Sara Gibertini, Flavia Blasevich, et al.Journal of Neuroimmunology|June 17, 2008
BDNF and its receptors in human myasthenic thymus: implications for cell fate in thymic pathologyAngela Berzi, C Korcan Ayata, Paola Cavalcante, et al.Biomedicines|June 24, 2022
Complement Activation Profile in Myasthenia Gravis Patients: Perspectives for Tailoring Anti-Complement TherapyNicola Iacomino, Fiammetta Vanoli, Rita Frangiamore, et al.International Immunology|March 25, 2004
Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical associationRenato Mantegazza, Piercarlo Cristaldini, Pia Bernasconi, et al.Pageof 8